Eli Lilly and Company - Current Ratio
LLY
Price:
$1098.13
Market Cap:
$1.03T
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for n...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
LLY
PE Ratio
[38.98]
ROE
[101.30%]
Current Ratio
[1.50]
Dividend Yield
[0.59%]
Enterprise Value
[1.07T]
Dividend History
The Current Ratio as of June 2026 (TTM) for Eli Lilly and Company (LLY) is 1.50
According to Eli Lilly and Company’s latest financial reports and current stock price. The company's current Current Ratio is 1.50. This represents a change of 1.48% compared to the average of 1.47 of the last 4 quarters.
Eli Lilly and Company (LLY) Historical Current Ratio (quarterly & annually)
How has LLY Current Ratio performed in the past?
The mean historical Current Ratio of Eli Lilly and Company over the last ten years is 1.29. The current 1.50 Current Ratio has changed 11.47% with respect to the historical average. Over the past ten years (40 quarters), LLY's Current Ratio was at its highest in in the September 2018 quarter at 1.91. The Current Ratio was at its lowest in in the December 2023 quarter at 0.94.
Average
1.29
Median
1.27
Minimum
0.94
Maximum
1.73
Eli Lilly and Company (LLY) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Eli Lilly and Company Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 36.87%
Maximum Annual Current Ratio = 1.73
Minimum Annual Increase = -32.65%
Minimum Annual Current Ratio = 0.94
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.58 | 36.87% |
| 2024 | 1.15 | 22.40% |
| 2023 | 0.94 | -10.42% |
| 2022 | 1.05 | -14.16% |
| 2021 | 1.23 | -12.38% |
| 2020 | 1.40 | 20.16% |
| 2019 | 1.16 | -32.65% |
| 2018 | 1.73 | 30.85% |
| 2017 | 1.32 | -3.89% |
| 2016 | 1.37 | -10.04% |
Eli Lilly and Company (LLY) Average Current Ratio
How has LLY Current Ratio performed in the past?
The current Current Ratio of Eli Lilly and Company (LLY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.23
5-year avg
1.19
10-year avg
1.29
Eli Lilly and Company (LLY) Current Ratio vs. Peers
How is LLY’s Current Ratio compared to its peers?
Eli Lilly and Company’s Current Ratio is greater than Johnson & Johnson (1.03), greater than AstraZeneca PLC (0.91), greater than AbbVie Inc. (0.80), greater than Novartis AG (0.85), greater than Amgen Inc. (1.26), greater than Novo Nordisk A/S (0.79), greater than Merck & Co., Inc. (1.30), less than Gilead Sciences, Inc. (1.97), greater than Pfizer Inc. (1.25), greater than Sanofi (1.01),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.03 | $549.78B | |
| 0.91 | $271.29B | |
| 0.80 | $382.74B | |
| 0.85 | $280.64B | |
| 1.26 | $182.21B | |
| 0.79 | $191.93B | |
| 1.30 | $281.24B | |
| 1.97 | $153.66B | |
| 1.25 | $143.74B | |
| 1.01 | $101.89B |
Build a custom stock screener for Eli Lilly and Company (LLY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eli Lilly and Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Eli Lilly and Company (LLY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Eli Lilly and Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Eli Lilly and Company's Current Ratio?
How is the Current Ratio calculated for Eli Lilly and Company (LLY)?
What is the highest Current Ratio for Eli Lilly and Company (LLY)?
What is the 3-year average Current Ratio for Eli Lilly and Company (LLY)?
What is the 5-year average Current Ratio for Eli Lilly and Company (LLY)?
How does the current Current Ratio for Eli Lilly and Company (LLY) compare to its historical average?